BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22752652)

  • 1. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis.
    Blomberg BA; Moghbel MC; Saboury B; Stanley CA; Alavi A
    Mol Imaging Biol; 2013 Feb; 15(1):97-105. PubMed ID: 22752652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.
    Treglia G; Mirk P; Giordano A; Rufini V
    Pediatr Radiol; 2012 Nov; 42(11):1372-9. PubMed ID: 22885604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
    Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
    Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: a meta-analysis.
    Yang J; Hao R; Zhu X
    Nucl Med Commun; 2013 Apr; 34(4):347-53. PubMed ID: 23376859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
    Subramaniam RM; Karantanis D; Peller PJ
    J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterogeneity of focal forms of congenital hyperinsulinism.
    Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
    Kühnen P; Matthae R; Arya V; Hauptmann K; Rothe K; Wächter S; Singer M; Mohnike W; Eberhard T; Raile K; Lauffer LM; Iakoubov R; Hussain K; Blankenstein O
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):847-54. PubMed ID: 24750227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
    Ismail D; Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: improving surgery and outcome in focal hyperinsulinism. Commentary to Mohnike et al.: Proposal for a standardized protocol for F-DOPA-PET (PET/CT) in congenital hyperinsulinism (Horm Res 2006;66:40-42).
    Shield JP
    Horm Res; 2006; 66(1):43-4. PubMed ID: 16710095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.